Your browser doesn't support javascript.
loading
Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol-PM) in patients with solid tumors.
Lim, W T; Tan, E H; Toh, C K; Hee, S W; Leong, S S; Ang, P C S; Wong, N S; Chowbay, B.
Affiliation
  • Lim WT; Department of Medical Oncology.
  • Tan EH; Department of Medical Oncology.
  • Toh CK; Department of Medical Oncology.
  • Hee SW; Biostatistic Unit, Division of Clinical Trials and Epidemiological Sciences.
  • Leong SS; Department of Medical Oncology.
  • Ang PCS; Department of Medical Oncology.
  • Wong NS; Department of Medical Oncology.
  • Chowbay B; Clinical Pharmacology Laboratory, Division of Medical Sciences, Humphrey Oei Institute of Cancer Research, National Cancer Centre, Singapore. Electronic address: ctebal@nccs.com.sg.
Ann Oncol ; 21(2): 382-388, 2010 Feb.
Article in En | MEDLINE | ID: mdl-19633055
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paclitaxel / Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2010 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paclitaxel / Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2010 Document type: Article Country of publication: